6 asymptomatic COVID-19 cases imported from overseas & HK raise Macau’s tally to 119

2022-05-16 03:24
BY Tony Wong
Comment:0

Four local residents who returned to Macau from Italy, the United States, Canada and Singapore on Saturday respectively have tested positive for COVID-19, Macau’s Novel Coronavirus Response and Coordination Centre announced yesterday.

The first three of the four asymptomatic patients returned to Macau on a connecting flight from Singapore.

According to a statement by the centre, the first patient is a 30-year-old man who returned from Italy, having previously received two mRNA jabs. The second patient, a 21-year-old man who returned from the US, received his first and second inactivated jab in February and March last year respectively, before receiving an mRNA dose as his booster jab in February this year.

The third patient is a 61-year-old man who returned from Canada, having previously received three mRNA jabs, while the fourth patient is a 26-year-old woman who returned from Singapore, having previously received three Pfizer mRNA jabs, according to the statement.

All four patients tested positive for the novel coronavirus upon arrival at the local airport on Saturday, because of which they were immediately transferred to the Health Bureau’s (SSM) Public Health Clinical Centre for isolation.

Meanwhile, the Novel Coronavirus Response and Coordination Centre has also announced two other asymptomatic COVID-19 cases imported from Hong Kong.

Both are local residents.

According to a statement by the centre on Friday, the first patient is a 46-year-old woman who had previously received two mRNA jabs, while the second patient is a 34-year-old woman who had previously received three mRNA jabs.

Both tested positive for the novel coronavirus upon arrival in Macau on Thursday, because of which they were then transferred to the Public Health Clinical Centre for isolation.

The six cases have raised Macau’s asymptomatic COVID-19 tally to 119.

Macau’s total number of confirmed COVID-19 cases remains at 82.


3 “re-positive” returnees from HK & Canada

Meanwhile, the Novel Coronavirus Response and Coordination Centre has announced three COVID-19 “re-positive” cases imported from Hong Kong and Canada.

A COVID-19 “re-positive” case means that a person has tested positive for the novel coronavirus again in a nucleic acid test (NAT) after having previously been infected with COVID-19 and recovered.

According to a statement by the centre on Wednesday, the first “re-positive” patient is a 20-year-old local woman who returned from Hong Kong on Tuesday week. The young woman, who received two mRNA jabs in July last year, holds a certificate confirming that her condition temporarily renders her unsuitable to receive a third dose as a booster jab.

The woman tested positive for the novel coronavirus upon arrival in Macau, because of which she was then transferred to the Public Health Clinical Centre for isolation.

The woman was diagnosed with the novel coronavirus disease in March, because of which her case has been classified as a “re-positive” case.

The other two “re-positive” cases were announced in yesterday’s statement by the centre. They comprise a 36-year-old local man and a 23-year-old local woman who returned from Hong Kong and Canada on Saturday respectively. The man, who had previously received two mRNA jabs, was diagnosed with COVID-19 in March, while the woman, who had previously received three Pfizer mRNA jabs, was diagnosed with COVID-19 in January. Both tested positive for the novel coronavirus upon their respective arrivals in Macau, after which they were transferred to the Public Health Clinical Centre for isolation.

COVID-19 “re-positive” cases are not classified as confirmed COVID-19 cases for Macau, neither are they classified as asymptomatic COVID-19 cases for Macau.


A girl poses with her mother for photos after getting vaccinated against COVID-19 at the Macau Forum inoculation facility at the weekend. The sign held by the girl reads “we are all defenders”. Photo: DSEDJ


0 COMMENTS

Leave a Reply